TwinBeech Capital’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-114,531
Closed -$664K 922
2024
Q3
$664K Buy
+114,531
New +$736K 0.01% 550
2022
Q3
Sell
-25,199
Closed -$361K 808
2022
Q2
$361K Buy
25,199
+7,368
+41% +$124K 0.02% 443
2022
Q1
$337K Buy
+17,831
New +$347K 0.01% 419

Other funds holding TMCI

TwinBeech Capital's TMCI Position: Q4 2024 in Review

TwinBeech Capital sold out of Treace Medical Concepts (TMCI) in Q4 2024, closing a stake of 114,531 shares — an estimated $664K sold.

TwinBeech Capital first reported a position in TMCI in Q1 2022 and held it in 3 quarters. The position peaked at $664K in Q3 2024. 135 funds tracked by Wall St. Rank hold TMCI as of Q4 2024.

  • TwinBeech Capital reported no remaining Treace Medical Concepts position as of Q4 2024 after selling out during the quarter.
  • TwinBeech Capital sold 114,531 Treace Medical Concepts shares in Q4 2024, an estimated $664K.
  • TwinBeech Capital first reported a position in Treace Medical Concepts in Q1 2022 and held it in 3 quarters.
  • TwinBeech Capital's Treace Medical Concepts position peaked at $664K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2024.

Based on TwinBeech Capital's 13F filing for Q4 2024, filed 14 Feb 2025.